Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has raised concerns in patients with inflammatory bowel disease (IBD), not only due to consequences of coronavirus disease 2019 itself but also as a possible cause of IBD relapse. The main objective of this study was to assess th...

Descripción completa

Detalles Bibliográficos
Autores principales: Papa, Alfredo, Scaldaferri, Franco, Covino, Marcello, Tursi, Antonio, Furfaro, Federica, Mocci, Giammarco, Lopetuso, Loris Riccardo, Maconi, Giovanni, Bibbò, Stefano, Fiorani, Marcello, Laterza, Lucrezia, Mignini, Irene, Napolitano, Daniele, Parisio, Laura, Pizzoferrato, Marco, Privitera, Giuseppe, Pugliese, Daniela, Schepis, Tommaso, Schiavoni, Elisa, Settanni, Carlo Romano, Vetrone, Lorenzo Maria, Armuzzi, Alessandro, Danese, Silvio, Gasbarrini, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029341/
https://www.ncbi.nlm.nih.gov/pubmed/35453593
http://dx.doi.org/10.3390/biomedicines10040843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029341/
https://www.ncbi.nlm.nih.gov/pubmed/35453593
http://dx.doi.org/10.3390/biomedicines10040843

Ejemplares similares